谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

173P First-in-human study to evaluate the safety and clinical activity of FS222: A tetravalent bispecific antibody targeting PD-L1 and CD137, in patients with advanced solid tumors

G.A. De Velasco Oria,E. Garralda,V. Moreno Garcia,I. Melero,I. Victoria Ruiz,A. Indacochea, A. Cervantes,A. Oberoi,D. Jones,M.A. Lakins,L. Kayitalire

Immuno-Oncology and Technology（2022）

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要